Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexander Knuth

Showing results (41-50 of 130) with videos related to

Pageof 13
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|March 9, 2002
Impact of antigen presentation on TCR modulation and cytokine release: implications for detection and sorting of antigen-specific CD8+ T cells using HLA-A2 wild-type or HLA-A2 mutant tetrameric complexesElke Jäger, Russell Salter, Chiara Castelli, et al.
Cancer Immunology Research|July 5, 2015
Rational Combination of Immunotherapies with Clinical Efficacy in Mice with Advanced CancerAli Bransi, Oscar Camilo Salgado, Michal Beffinger, et al.
Cancer Immunity|May 16, 2003
Identification of tumor-restricted antigens NY-BR-1, SCP-1, and a new cancer/testis-like antigen NW-BR-3 by serological screening of a testicular library with breast cancer serumDirk Jäger, Marc Unkelbach, Claudia Frei, et al.
Advances in Cancer Research|July 25, 2006
NY-ESO-1: review of an immunogenic tumor antigenSacha Gnjatic, Hiroyoshi Nishikawa, Achim A Jungbluth, et al.
International Journal of Cancer|February 13, 2007
NY-ESO-1 protein expression in primary breast carcinoma and metastases: correlation with CD8+ T-cell and CD79a+ plasmacytic/B-cell infiltrationJean-Philippe Theurillat, Fabienne Ingold, Claudia Frei, et al.
Plos One|July 9, 2011
Expression of MAGE-C1/CT7 and MAGE-C2/CT10 predicts lymph node metastasis in melanoma patientsAlessandra Curioni-Fontecedro, Natko Nuber, Daniela Mihic-Probst, et al.
Anticancer Research|April 16, 2010
Yeast-based identification of prostate tumor antigens provides an effective vaccine platformVolker Jung, Eliane Fischer, Jochen Imig, et al.
International Journal of Cancer|January 5, 2002
Improved detection of melanoma antigen-specific T cells expressing low or high levels of CD8 by HLA-A2 tetramers presenting a Melan-A/Mart-1 peptide analogueMarkus J Maeurer, Antje Necker, Russell D Salter, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 23, 2003
Cross-presentation of HLA class I epitopes from exogenous NY-ESO-1 polypeptides by nonprofessional APCsSacha Gnjatic, Djordje Atanackovic, Mitsutoshi Matsuo, et al.
Virchows Archiv : an International Journal of Pathology|March 27, 2013
Expression of MAGE-C1/CT7 and selected cancer/testis antigens in ovarian borderline tumours and primary and recurrent ovarian carcinomasAnne-Katrin Zimmermann, Jochen Imig, Agnes Klar, et al.
Pageof 13

Showing results (41-50 of 130) with videos related to

Sort By:
Pageof 13
Journal of Immunology (Baltimore, Md. : 1950)|March 9, 2002
Impact of antigen presentation on TCR modulation and cytokine release: implications for detection and sorting of antigen-specific CD8+ T cells using HLA-A2 wild-type or HLA-A2 mutant tetrameric complexesElke Jäger, Russell Salter, Chiara Castelli, et al.
Cancer Immunology Research|July 5, 2015
Rational Combination of Immunotherapies with Clinical Efficacy in Mice with Advanced CancerAli Bransi, Oscar Camilo Salgado, Michal Beffinger, et al.
Cancer Immunity|May 16, 2003
Identification of tumor-restricted antigens NY-BR-1, SCP-1, and a new cancer/testis-like antigen NW-BR-3 by serological screening of a testicular library with breast cancer serumDirk Jäger, Marc Unkelbach, Claudia Frei, et al.
Advances in Cancer Research|July 25, 2006
NY-ESO-1: review of an immunogenic tumor antigenSacha Gnjatic, Hiroyoshi Nishikawa, Achim A Jungbluth, et al.
International Journal of Cancer|February 13, 2007
NY-ESO-1 protein expression in primary breast carcinoma and metastases: correlation with CD8+ T-cell and CD79a+ plasmacytic/B-cell infiltrationJean-Philippe Theurillat, Fabienne Ingold, Claudia Frei, et al.
Plos One|July 9, 2011
Expression of MAGE-C1/CT7 and MAGE-C2/CT10 predicts lymph node metastasis in melanoma patientsAlessandra Curioni-Fontecedro, Natko Nuber, Daniela Mihic-Probst, et al.
Anticancer Research|April 16, 2010
Yeast-based identification of prostate tumor antigens provides an effective vaccine platformVolker Jung, Eliane Fischer, Jochen Imig, et al.
International Journal of Cancer|January 5, 2002
Improved detection of melanoma antigen-specific T cells expressing low or high levels of CD8 by HLA-A2 tetramers presenting a Melan-A/Mart-1 peptide analogueMarkus J Maeurer, Antje Necker, Russell D Salter, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 23, 2003
Cross-presentation of HLA class I epitopes from exogenous NY-ESO-1 polypeptides by nonprofessional APCsSacha Gnjatic, Djordje Atanackovic, Mitsutoshi Matsuo, et al.
Virchows Archiv : an International Journal of Pathology|March 27, 2013
Expression of MAGE-C1/CT7 and selected cancer/testis antigens in ovarian borderline tumours and primary and recurrent ovarian carcinomasAnne-Katrin Zimmermann, Jochen Imig, Agnes Klar, et al.
Pageof 13